<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="current pharmacotherapies, as well as fuel the search for new" exact="cancer" post="pharmacotherapies, to activate apoptotic pathways in neoplastic cells. Structure"/>
 <result pre="nuclear factor NFÎºB â€&quot; which can stimulate the growth of" exact="cancer" post="cells â€&quot; by promoting its interaction with DNA through"/>
 <result pre="pathological conditions such as arterial hypertension, insulin resistance or abdominal" exact="obesity" post="â€&quot; which are part of the metabolic syndrome â€&quot;"/>
 <result pre="resistance or abdominal obesity â€&quot; which are part of the" exact="metabolic syndrome" post="â€&quot; and in chronic obstructive pulmonary disease (COPD), asthma,"/>
 <result pre="which are part of the metabolic syndrome â€&quot; and in" exact="chronic obstructive pulmonary disease" post="(COPD), asthma, cystic fibrosis, as well as in Alzheimerâ€™s"/>
 <result pre="syndrome â€&quot; and in chronic obstructive pulmonary disease (COPD), asthma," exact="cystic fibrosis," post="as well as in Alzheimerâ€™s and Parkinsonâ€™s disease, and"/>
 <result pre="intensify the process of oncogenesis29. Therefore, some preparations used in" exact="cancer" post="pharmacotherapy are characterised by the ability to permanently bind"/>
 <result pre="effects are necessary to affect botulinum nerve cells (BoNT) and" exact="tetanus" post="neurotoxin (TeNT). It has been observed that blocking of"/>
 <result pre="in the treatment of advanced, therapy-resistant cancers (e.g. non-small cell" exact="lung cancer," post="pancreatic, breast, and gastrointestinal cancers, as well as multiple"/>
 <result pre="anti-proliferative effects than cis-platin. In the case of multi-drug resistant" exact="lung cancer" post="cells insensitive to cisplatin, ruthenium complexes have been shown"/>
 <result pre="effects than cis-platin. In the case of multi-drug resistant lung" exact="cancer" post="cells insensitive to cisplatin, ruthenium complexes have been shown"/>
 <result pre="the activity of TrxR also have an antiproliferative effect on" exact="cancer" post="cells such as breast adenoma and colorectal cancer cells81,82."/>
 <result pre="have an antiproliferative effect on cancer cells such as breast" exact="adenoma" post="and colorectal cancer cells81,82. However, copper (I) alkyl phosphine"/>
 <result pre="antiproliferative effect on cancer cells such as breast adenoma and" exact="colorectal cancer" post="cells81,82. However, copper (I) alkyl phosphine complexes have greater"/>
 <result pre="effect on cancer cells such as breast adenoma and colorectal" exact="cancer" post="cells81,82. However, copper (I) alkyl phosphine complexes have greater"/>
 <result pre="However, copper (I) alkyl phosphine complexes have greater cytotoxicity towards" exact="cancer" post="cells than analogous compounds containing Auâ€‰+â€‰and Agâ€‰+â€‰as a central"/>
 <result pre="compound suggests that the toxic action of Cu-containing complexes against" exact="cancer" post="cells does not result from apoptosis, but is caused"/>
 <result pre="special attention because of its preferential effect on easily proliferating" exact="cancer" post="cells90. This effect was noticed during a cell viability"/>
 <result pre="viability assay performed on human keratinocytes (HaCaT)90,91 as well as" exact="neuroblastoma" post="(SH-SY5Y)90,91 and glioblastoma (U87 and U87-TxR) cell lines92. Despite"/>
 <result pre="cell lines92. Despite the effective selective action of DVD-445 against" exact="cancer" post="cells, it has been observed that neuroblastoma cells remain"/>
 <result pre="of DVD-445 against cancer cells, it has been observed that" exact="neuroblastoma" post="cells remain viable at approximately 80%90â€&quot;92. In addition, some"/>
 <result pre="also show inhibitory activity against TrxR activity, but not in" exact="cancer" post="cells90. Therefore, the search for other TrxR inhibitors that"/>
 <result pre="inhibit the action of other pro-survival enzymes in relation to" exact="cancer" post="cells is ongoing. Such a group of compounds includes"/>
 <result pre="important in the process of carcinogenesis, because carbonic anhydrase protects" exact="cancer" post="cells against acidification and hypoxia, preventing them death. This"/>
 <result pre="preventing them death. This &quot;hybrid&quot; exhibits significant cytotoxicity to the" exact="pancreatic cancer" post="cell line (PANC-1) compared to co-administered combinations of TrxR"/>
 <result pre="them death. This &quot;hybrid&quot; exhibits significant cytotoxicity to the pancreatic" exact="cancer" post="cell line (PANC-1) compared to co-administered combinations of TrxR"/>
 <result pre="anhydrase inhibitors94. Consequently, due to the efficacy and preference for" exact="cancer" post="cells, the synthesis and further research on Michael acceptors"/>
 <result pre="cells References TrxR1 TrxR2 Pt2+ cis-platincarboplatinoksaliplatin + + proliferation decrease" exact="breast cancer" post="ovarian cancer lung cancer leukaemia mice sarcoma 42,63 Au+"/>
 <result pre="References TrxR1 TrxR2 Pt2+ cis-platincarboplatinoksaliplatin + + proliferation decrease breast" exact="cancer" post="ovarian cancer lung cancer leukaemia mice sarcoma 42,63 Au+"/>
 <result pre="TrxR1 TrxR2 Pt2+ cis-platincarboplatinoksaliplatin + + proliferation decrease breast cancer" exact="ovarian cancer" post="lung cancer leukaemia mice sarcoma 42,63 Au+ auranofin and"/>
 <result pre="TrxR2 Pt2+ cis-platincarboplatinoksaliplatin + + proliferation decrease breast cancer ovarian" exact="cancer" post="lung cancer leukaemia mice sarcoma 42,63 Au+ auranofin and"/>
 <result pre="Pt2+ cis-platincarboplatinoksaliplatin + + proliferation decrease breast cancer ovarian cancer" exact="lung cancer" post="leukaemia mice sarcoma 42,63 Au+ auranofin and its derivatives"/>
 <result pre="cis-platincarboplatinoksaliplatin + + proliferation decrease breast cancer ovarian cancer lung" exact="cancer" post="leukaemia mice sarcoma 42,63 Au+ auranofin and its derivatives"/>
 <result pre="proliferation decrease breast cancer ovarian cancer lung cancer leukaemia mice" exact="sarcoma" post="42,63 Au+ auranofin and its derivatives + + increase"/>
 <result pre="ROS level apoptosis antiproliferation increase of intracellular concentration of Ca2+" exact="breast cancer" post="ovarian cancercervical cancerlung cancer colorectal cancer melanoma 62,65,66,67,69,95 Ru3+"/>
 <result pre="level apoptosis antiproliferation increase of intracellular concentration of Ca2+ breast" exact="cancer" post="ovarian cancercervical cancerlung cancer colorectal cancer melanoma 62,65,66,67,69,95 Ru3+"/>
 <result pre="of intracellular concentration of Ca2+ breast cancer ovarian cancercervical cancerlung" exact="cancer" post="colorectal cancer melanoma 62,65,66,67,69,95 Ru3+ thiazole and polypyridyl complexes"/>
 <result pre="intracellular concentration of Ca2+ breast cancer ovarian cancercervical cancerlung cancer" exact="colorectal cancer" post="melanoma 62,65,66,67,69,95 Ru3+ thiazole and polypyridyl complexes ++ +"/>
 <result pre="concentration of Ca2+ breast cancer ovarian cancercervical cancerlung cancer colorectal" exact="cancer" post="melanoma 62,65,66,67,69,95 Ru3+ thiazole and polypyridyl complexes ++ +"/>
 <result pre="+ proliferation decrease apoptosis change of redox enviroment breast cancerlung" exact="cancer" post="liver cancer melanoma rat prostate cancer 76,78,96 Sn4+ Â"/>
 <result pre="proliferation decrease apoptosis change of redox enviroment breast cancerlung cancer" exact="liver cancer" post="melanoma rat prostate cancer 76,78,96 Sn4+ Â + +"/>
 <result pre="decrease apoptosis change of redox enviroment breast cancerlung cancer liver" exact="cancer" post="melanoma rat prostate cancer 76,78,96 Sn4+ Â + +"/>
 <result pre="of redox enviroment breast cancerlung cancer liver cancer melanoma rat" exact="prostate cancer" post="76,78,96 Sn4+ Â + + proliferation decrease breast cancer"/>
 <result pre="redox enviroment breast cancerlung cancer liver cancer melanoma rat prostate" exact="cancer" post="76,78,96 Sn4+ Â + + proliferation decrease breast cancer"/>
 <result pre="rat prostate cancer 76,78,96 Sn4+ Â + + proliferation decrease" exact="breast cancer" post="colorectal cancer 77 Gd2+ motexafin gadolinium (MGd) + +"/>
 <result pre="prostate cancer 76,78,96 Sn4+ Â + + proliferation decrease breast" exact="cancer" post="colorectal cancer 77 Gd2+ motexafin gadolinium (MGd) + +"/>
 <result pre="cancer 76,78,96 Sn4+ Â + + proliferation decrease breast cancer" exact="colorectal cancer" post="77 Gd2+ motexafin gadolinium (MGd) + + release of"/>
 <result pre="76,78,96 Sn4+ Â + + proliferation decrease breast cancer colorectal" exact="cancer" post="77 Gd2+ motexafin gadolinium (MGd) + + release of"/>
 <result pre="from metalothioneins increase in ROS level apoptosis lung cancerovarian cancerB-cell" exact="lymphoma" post="79,80 Rh+ carbene rhodium derivatives + + proliferation decrease"/>
 <result pre="derivatives + + proliferation decrease increase in ROS level neuroblastoma," exact="colorectal cancer" post="liver cancerpancreatic cancer breast cancerprostate cancer 81,82 Cu+ Â"/>
 <result pre="+ + proliferation decrease increase in ROS level neuroblastoma, colorectal" exact="cancer" post="liver cancerpancreatic cancer breast cancerprostate cancer 81,82 Cu+ Â"/>
 <result pre="decrease increase in ROS level neuroblastoma, colorectal cancer liver cancerpancreatic" exact="cancer" post="breast cancerprostate cancer 81,82 Cu+ Â + + paraptosis"/>
 <result pre="ROS level neuroblastoma, colorectal cancer liver cancerpancreatic cancer breast cancerprostate" exact="cancer" post="81,82 Cu+ Â + + paraptosis breast cancerovarian cancercervical"/>
 <result pre="chloride ++ + increase in ROS level redox balance control" exact="ovarian cancer" post="75 The â€œ++â€� symbol indicates an enzyme isoform for"/>
 <result pre="++ + increase in ROS level redox balance control ovarian" exact="cancer" post="75 The â€œ++â€� symbol indicates an enzyme isoform for"/>
 <result pre="well as drive changes that result in the death of" exact="cancer" post="cells by apoptosis, the search for compounds that are"/>
 <result pre="at T100 is needed for its anti-apoptotic activity in HepG2" exact="cancer" post="cells. Life Sci2010;87:254â€&quot;60.20619274 6AhsanMK, LekliI, RayD, et al.Redox regulation"/>
 <result pre="29LincolnDT, Al-YatamaF, MohammedFM, et al.Thioredoxin and thioredoxin reductase expression in" exact="thyroid cancer" post="depends on tumour aggressiveness. Anticancer Res2010;30:767â€&quot;75.20392995 30MahmoodDFD, AbderrazakA, El"/>
 <result pre="Al-YatamaF, MohammedFM, et al.Thioredoxin and thioredoxin reductase expression in thyroid" exact="cancer" post="depends on tumour aggressiveness. Anticancer Res2010;30:767â€&quot;75.20392995 30MahmoodDFD, AbderrazakA, El"/>
 <result pre="methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets" exact="leukemia" post="cells in AML. Blood2011;118:2830â€&quot;9.21734239 40MorrisonJA, PikeLA, SamsSB, et al.Thioredoxin"/>
 <result pre="al.Thioredoxin interacting protein (TXNIP) is a novel tumor suppressor in" exact="thyroid cancer." post="Mol Cancer2014;13:6224645981 41FangJ, LuJ, HolmgrenAThioredoxin reductase is irreversibly modified"/>
 <result pre="et al.Thioredoxin 1 modulates apoptosis induced by bioactive compounds in" exact="prostate cancer" post="cells. Redox Biol2017;12:634â€&quot;47.28391184 44LuJ, PappLV, FangJ, et al.Inhibition of"/>
 <result pre="al.Thioredoxin 1 modulates apoptosis induced by bioactive compounds in prostate" exact="cancer" post="cells. Redox Biol2017;12:634â€&quot;47.28391184 44LuJ, PappLV, FangJ, et al.Inhibition of"/>
 <result pre="PX-12 (1-methylpropyl 2-imidazolyl disulfide) decreases thioredoxin-1 and VEGF levels in" exact="cancer" post="patient plasma. J Lab Clin Med2006;147:83â€&quot;90.16459166 55BakerAF, AdabKN, RaghunandN,"/>
 <result pre="et al.Inhibition of thioredoxin 1 leads to apoptosis in drug-resistant" exact="multiple myeloma." post="Oncotarget2015;6:15410â€&quot;24.25945832 58LiGZ, LiangHF, LiaoB, et al.PX-12 inhibits the growth"/>
 <result pre="of gold(I) N-heterocyclic carbene complexes that are selectively toxic to" exact="cancer" post="cells and target protein selenols in preference to thiols."/>
 <result pre="et al.Auranofin, an inhibitor of thioredoxin reductase, induces apoptosis in" exact="hepatocellular carcinoma" post="Hep3B cells by generation of reactive oxygen species. Gen"/>
 <result pre="Biophys2017;36:117â€&quot;28.28218611 68ScalconV, BindoliA, RigobelloMPSignificance of the mitochondrial thioredoxin reductase in" exact="cancer" post="cells: an update on role, targets and inhibitors. Free"/>
 <result pre="Commun2006;343:873â€&quot;8.16564501 74ZhangJ, LiX, HanX, et al.Targeting the thioredoxin system for" exact="cancer" post="therapy. Trends Pharmacol Sci2017;38:794â€&quot;808.28648527 75CittaA, FoldaA, ScutariG, et al.Inhibition"/>
 <result pre="derived partial structures: TrxR inhibition, cytotoxicity and activity in resistant" exact="cancer" post="cells. Eur J Med Chem2014;87:794â€&quot;800.25440880 78ZengL, ChenY, LiuJ, et"/>
 <result pre="Chem2006;281:10691â€&quot;7.16481328 80MagdaD, MillerRA.Motexafin gadolinium: a novel redox active drug for" exact="cancer" post="therapy. Semin Cancer Biol2006;16:466â€&quot;76.17112739 81OehningerL, KÃ¼sterLN, SchmidtC, et al.A"/>
 <result pre="of DVD-445 as a lead thioredoxin reductase (TrxR) inhibitor for" exact="cancer" post="therapy: optimization of potency and evaluation of anticancer potential."/>
 <result pre="92JovanoviÄ‡M, DragojM, ZhukovskyD, et al.Novel TrxR1 inhibitors show potential for" exact="glioma" post="treatment by suppressing the invasion and sensitizing glioma cells"/>
 <result pre="potential for glioma treatment by suppressing the invasion and sensitizing" exact="glioma" post="cells to chemotherapy. Front Mol Biosci2020;7:586146.33134322 93KrasavinM, Å½alubovskisR, GrandÄ�neA,"/>
 <result pre="of thioredoxin reductase by auranofin induces apoptosis in cisplatin-resistant human" exact="ovarian cancer" post="cells. Free Radic Biol Med2007;42:872â€&quot;81.17320769 96LuoZ, YuL, YangF, et"/>
 <result pre="thioredoxin reductase by auranofin induces apoptosis in cisplatin-resistant human ovarian" exact="cancer" post="cells. Free Radic Biol Med2007;42:872â€&quot;81.17320769 96LuoZ, YuL, YangF, et"/>
 <result pre="et al.Ruthenium polypyridyl complexes as inducer of ROS-mediated apoptosis in" exact="cancer" post="cells by targeting thioredoxin reductase. Metallomics2014;6:1480â€&quot;90.24823440"/>
</results>
